As of May 2026 Alnylam Pharmaceuticals has a market cap of A$54.81 Billion. This makes Alnylam Pharmaceuticals the world's 632th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 3rd, 2026 the market cap of Alnylam Pharmaceuticals was reported to be: